The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation provided data for the excellent technical quality of the assay as well as the high sensitivity of our monoclonal assay for the patients tested. The data of the evaluation also resulted in a presentation at the annual meeting of the Belgian Society For Clinical Biology.
Contact
BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search in Blog
Archive
April 2010 [1]
March 2010 [1]
February 2010 [1]
January 2010 [1]
December 2009 [3]
November 2009 [3]
October 2009 [1]
September 2009 [2]
August 2009 [2]
July 2009 [1]
June 2009 [2]
April 2009 [2]
February 2009 [4]
March 2010 [1]
February 2010 [1]
January 2010 [1]
December 2009 [3]
November 2009 [3]
October 2009 [1]
September 2009 [2]
August 2009 [2]
July 2009 [1]
June 2009 [2]
April 2009 [2]
February 2009 [4]
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | BÜHLMANN Industrial | Customer Relations | About Us |
Contact |